Terumo

Terumo Contract Manufacturing & Development (CDMO) Profile

Currently, the Terumo Group includes three companies that operate in over 160 countries and regions around the world, providing patients, a variety of medical settings, and the pharmaceutical industry with over 50,000 products and services.
As part of Terumo Medical Care Solutions Company, the Pharmaceutical Solutions Division (PSD) is a leading manufacturer of injection solutions, primary containers, infusion therapy devices, and Contract Development and Manufacturing Organization (CDMO) for parenteral drugs to global customers.
With over 20 years of integrated CDMO experience in Japan, collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral drug delivery, PSD now offers these global end-to-end services to support customers to launch their products on the worldwide market.
Terumo’s unique capabilities are integrated into our CDMO solutions and offer end-to-end services starting from primary containers (pre-fillable syringes and customized containers) manufacturing and drug-device combination product development, aseptic fill & finish, autoinjector and safety device assembly, regulatory support, and commercial launch.

CDMO Services:
Biologics; Packaging; Medical Devices Liquids; Pre-Filled Syringes (PFS) Drug Delivery System; ICH Stability Testing; Formulation Development; Process Development Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; Protein Vaccines

Year Founded: 1921

Head Office: Somerset, Japan

Number of Facilities: 45415

Facility locations: East Asia

Website: Visit the Terumo website

Linkedin: Connect on Linkedin